About Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals is a company based in Cambridge (United States) founded in 1997 was acquired by Progenics in January 2013.. Molecular Insight Pharmaceuticals operates in a competitive market with competitors including ImaginAb, MDxHealth, AC Immune, GenomeDx Biosciences and APRINOIA, among others.
- Headquarter Cambridge, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Molecular Insight Pharmaceuticals Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Molecular Insight Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $2.0M
-
First Round
First Round
(01 Aug 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2011 | Amount | Grant - Molecular Insight Pharmaceuticals | Valuation |
investors |
|
| Sep, 2010 | Amount | Grant - Molecular Insight Pharmaceuticals | Valuation |
investors |
|
| Sep, 2010 | Amount | Grant - Molecular Insight Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Progenics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Imaging compounds & targeted radiotherapies to detect and treat prostate cancer.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular Insight Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecular Insight Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Insight Pharmaceuticals Comparisons
Competitors of Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, MDxHealth, AC Immune, GenomeDx Biosciences and APRINOIA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Epigenetic tests for personalized cancer assessment and treatment.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Genomic tests for urologic cancers are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs and imaging agent for GI disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Molecular Insight Pharmaceuticals
Frequently Asked Questions about Molecular Insight Pharmaceuticals
When was Molecular Insight Pharmaceuticals founded?
Molecular Insight Pharmaceuticals was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Where is Molecular Insight Pharmaceuticals located?
Molecular Insight Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
What does Molecular Insight Pharmaceuticals do?
Molecular Insight Pharmaceuticals develops therapeutic radiopharmaceuticals and molecular imaging agents for use in oncology and cardiology. The company targets the development of a small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a systemic radiotherapy for relapsed and metastatic prostate cancer. Its products include technetium Tc 99m trofolastat, a clinical-stage molecular imaging agent for patients with metastatic prostate cancer; and 131I-MIP-1095, a prostate cancer therapy for systemic delivery of radiotherapy. As of January 18, 2013, Molecular Insight Pharmaceuticals operates as a subsidiary of Progenics Pharmaceuticals.